Literature DB >> 25974968

Correlating optical bench performance with clinical defocus curves in varifocal and trifocal intraocular lenses.

Ana B Plaza-Puche, Jorge L Alió, Scott MacRae, Len Zheleznyak, Esperanza Sala, Geunyoung Yoon.   

Abstract

PURPOSE: To investigate the correlations existing between a trifocal intraocular lens (IOL) and a varifocal IOL using the "ex vivo" optical bench through-focus image quality analysis and the clinical visual performance in real patients by study of the defocus curves.
METHODS: This prospective, consecutive, nonrandomized, comparative study included a total of 64 eyes of 42 patients. Three groups of eyes were differentiated according to the IOL implanted: 22 eyes implanted with the varifocal Lentis Mplus LS-313 IOL (Oculentis GmbH, Berlin, Germany); 22 eyes implanted with the trifocal FineVision IOL (Physiol, Liege, Belgium), and 20 eyes implanted with the monofocal Acrysof SA60AT IOL (Alcon Laboratories, Inc., Fort Worth, TX). Visual outcomes and defocus curve were evaluated postoperatively. Optical bench through-focus performance was quantified by computing an image quality metric and the cross-correlation coefficient between an unaberrated reference image and captured retinal images from a model eye with a 3.0-mm artificial pupil.
RESULTS: Statistically significant differences among defocus curves of different IOLs were detected for the levels of defocus from -4.00 to -1.00 diopters (D) (P < .01). Significant correlations were found between the optical bench image quality metric results and logMAR visual acuity scale in all groups (Lentis Mplus group: r = -0.97, P < .01; FineVision group: r = -0.82, P < .01; Acrys of group: r = -0.99, P < .01). Linear predicting models were obtained.
CONCLUSIONS: Significant correlations were found between logMAR visual acuity and image quality metric for the multifocal and monofocal IOLs analyzed. This finding enables surgeons to predict visual outcomes from the optical bench analysis. Copyright 2015, SLACK Incorporated.

Entities:  

Mesh:

Year:  2015        PMID: 25974968     DOI: 10.3928/1081597X-20150423-03

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  6 in total

1.  Visual acuity of pseudophakic patients predicted from in-vitro measurements of intraocular lenses with different design.

Authors:  Fidel Vega; Maria S Millán; Nuria Garzón; Irene Altemir; Francisco Poyales; Jose Manuel Larrosa
Journal:  Biomed Opt Express       Date:  2018-09-17       Impact factor: 3.732

2.  Preclinical metrics to predict through-focus visual acuity for pseudophakic patients.

Authors:  Aixa Alarcon; Carmen Canovas; Robert Rosen; Henk Weeber; Linda Tsai; Kendra Hileman; Patricia Piers
Journal:  Biomed Opt Express       Date:  2016-04-15       Impact factor: 3.732

3.  Psychophysical Vision Simulation of Diffractive Bifocal and Trifocal Intraocular Lenses.

Authors:  Wolfgang Brezna; Kirsten Lux; Nikolaus Dragostinoff; Christian Krutzler; Nicole Plank; Rainer Tobisch; Agnes Boltz; Gerhard Garhöfer; Reinhard Told; Katarzyna Witkowska; Leopold Schmetterer
Journal:  Transl Vis Sci Technol       Date:  2016-10-17       Impact factor: 3.283

4.  Trifocal intraocular lenses: a comparison of the visual performance and quality of vision provided by two different lens designs.

Authors:  Kjell G Gundersen; Rick Potvin
Journal:  Clin Ophthalmol       Date:  2017-06-08

5.  How does the world appear to patients with multifocal intraocular lenses?: a mobile model eye experiment.

Authors:  Eun Chul Kim; Kyung-Sun Na; Hyun Seung Kim; Ho Sik Hwang
Journal:  BMC Ophthalmol       Date:  2020-05-06       Impact factor: 2.209

6.  A Novel Intraocular Lens Simulator that Allows Patients to Experience the World Through Multifocal Intraocular Lenses Before Surgeries.

Authors:  Kyung-Sun Na; Seong-Jae Kim; Gahee Nam; Minji Ha; Woong-Joo Whang; Eun Chul Kim; Hyun-Seung Kim; Ho Sik Hwang
Journal:  Transl Vis Sci Technol       Date:  2022-03-02       Impact factor: 3.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.